TD Securities (USA)’s Bristol-Myers Squibb BMY Stock Holding History

TD Securities (USA)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$24K	Buy	377 +2	+0.5%	+$126	0.22%	40
2015 Q4	$26K	Sell	375 -578	-61%	-$38.2K	0.24%	36
2015 Q3	$56K	Sell	953 -674,164	-100%	-$42.8M	0.51%	40
2015 Q2	$44.9M	Buy	675,117 +78,021	+13%	+$5.14M	0.61%	38
2015 Q1	$38.5M	Sell	597,096 -32,797	-5%	-$2.05M	0.58%	39
2014 Q4	$37.2M	Buy	629,893 +49,975	+9%	+$2.82M	0.53%	40
2014 Q3	$29.7M	Buy	579,918 +601	+0.1%	+$30K	0.48%	45
2014 Q2	$28.1M	Buy	579,317 +39,807	+7%	+$1.96M	0.45%	47
2014 Q1	$28M	Sell	539,510 -41,411	-7%	-$2.2M	0.5%	41
2013 Q4	$30.9M	Buy	580,921 +17,243	+3%	+$878K	0.52%	39
2013 Q3	$26.1M	Buy	563,678 +3,614	+0.6%	+$159K	0.5%	40
2013 Q2	$25M	Buy	+560,064	New	+$24.3M	0.5%	38

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TD Securities (USA)'s BMY Position: Q1 2016 in Review

TD Securities (USA) increased its Bristol-Myers Squibb (BMY) stake by 0.53% in Q1 2016, buying an estimated $126 and bringing the position to 377 shares worth $24K. The position accounts for 0.22% of the portfolio, ranked #40.

TD Securities (USA) first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $44.9M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

TD Securities (USA) held 377 shares of Bristol-Myers Squibb worth $24K as of Q1 2016.
TD Securities (USA) bought 2 Bristol-Myers Squibb shares in Q1 2016, an estimated $126.
Bristol-Myers Squibb made up 0.22% of TD Securities (USA)'s portfolio in Q1 2016, its #40 holding.
TD Securities (USA) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s Bristol-Myers Squibb position peaked at $44.9M in Q2 2015.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.